)
Edge10 Jul 2026
Inside Take-Two: The Grand Anticipation
The story of how Take-Two Interactive built the empire behind Grand Theft Auto, Red Dead Redemption, and one of gaming's largest mobile portfolios.
BioInvent International
BioInvent International (BINV) investor relations material
BioInvent International KOL event summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.KOL event summary11 Jun, 2026
Introduction and agenda
Event featured leading experts discussing advances in hematology, focusing on follicular lymphoma (FL) and cutaneous T-cell lymphoma (CTCL), with presentations on BI-1206 and BI-1808, including new clinical data and Q&A sessions.
Agenda included overviews of treatment landscapes, unmet needs, clinical updates, commercial perspectives, and future development plans.
KOL background and credentials
Guilherme Perini, São Paulo Hospital, Brazil, and Stefan K. Barta, University of Pennsylvania, are leading experts in lymphoma and immunotherapy clinical trials.
Market insights and analysis
FL is a large, recurring market with 60,000 treated patients in US/EU and ~28,500 new cases annually; chemo-free regimens and new agents are improving outcomes but raise toxicity and access concerns.
CTCL is rare, chronic, and relapsing, with ~96% relapse rate and high unmet need for durable, tolerable therapies; current options have significant limitations.
Immuno-oncology market projected at $168bn with 14% CAGR, but faces bottlenecks like immunosuppressive microenvironment and tumor heterogeneity.
Market research indicates strong commercial opportunities for BI-1206 and BI-1808, with recurring revenue potential due to chronic, relapsing nature of diseases.
Explain BI-1206's ORR delta vs acalabrutinib
Compare BI-1206 safety vs R2-based SOC regimens
Detail BI-1808's myeloid reprogramming biomarkers
Safety as a commercial multiplier for BI-1206
BI-1808 advantages in Mycosis Fungoides
Pivotal trial timelines for 1206 and 1808
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from BioInvent International
- BI-1808 in ovarian cancer drives value with strong efficacy, safety, and pivotal study readiness.BINV
Aktiedagarna 2026 - Strong clinical progress in immuno-oncology with pivotal studies and key data readouts ahead.BINVJefferies Global Healthcare Conference 2026
- BI-1808 and BI-1206 deliver strong efficacy and safety, supporting pivotal development and market impact.BINVKOL event
- Promising clinical efficacy and safety for novel antibodies in major oncology indications.BINVCorporate presentation
- Promising clinical data for BI-1808 and BI-1206, but financial uncertainty remains.BINVQ1 2026
- Lead immuno-oncology antibodies show strong efficacy, with pivotal data expected in 2026.BINVCorporate presentation
- Strong clinical and financial progress sets up key oncology milestones for 2026–2027.BINVQ4 2025
- Lead programs BI-1206 and BI-1808 advance with strong data and solid financials in 2025.BINVQ3 2025
- Clinical progress continues, with robust liquidity despite lower sales and widened losses.BINVQ3 2024
Next BioInvent International earnings date
Q2 202627 Aug, 2026
BioInvent International
Next BioInvent International earnings date
Q2 202627 Aug, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage